Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Haas Jason sold 7,138 Ligand Pharmaceuticals Incorporated shares (Form 4)
Traded Aug 12, 2026 · Filed Aug 14, 2026
On Aug 12, 2026, Haas Jason (Director) sold 7,138 Ligand Pharmaceuticals Incorporated shares at US$292.81 for US$2.09M, leaving 3,981 shares. Filed Aug 14, 2026 (Form 4).
- Sold
- 7,138 shares
- Price
- US$292.81
- Value
- US$2.09M
- Holding after
- 3,981 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | Option exercise | 6,138 | US$51.56 | 11,119 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 7,138 | US$292.81 | 3,981 | Direct |
Source
Related
- Ligand Pharmaceuticals Incorporated
- Haas Jason
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Haas Jason · Jun 15, 2026
- Form 4 · Haas Jason · Jun 9, 2026
- Form 4 · Reardon Andrew · Oct 6, 2026
- Form 4 · Zimmermann Martine · Sep 24, 2026
- Form 4 · Zimmermann Martine · Sep 14, 2026
- Form 4 · Reardon Andrew · Sep 8, 2026
- Form 4 · Espinoza Octavio · Aug 14, 2026